Publications by authors named "Franklin Howard"

Claim this Profile
S
Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapy.
Manuel Modiano, Shanta Chawla, Jeffrey L Vacirca, Kenneth Crist, Howard Franklin

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Parallel Design Thorough QT Study With a Nested Crossover to Compare the Cardiac Safety of Amiselimod With Placebo and Positive Control in Healthy Volunteers.
Jimin Lee, Robert Lester, Terry O'Reilly, Ezra R Lowe, Neal E Slatkin, Howard Franklin

Clin Pharmacol Drug Dev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms.
Lucinda A Harris, Brooks D Cash, Karim Moftah, Howard Franklin

J Clin Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Acid Suppression Therapy on the Safety and Efficacy of Plecanatide: Analysis of Randomized Phase III Trials.
Baharak Moshiree, Philip Schoenfeld, Howard Franklin, Ali Rezaie

Clin Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P014 Analysis of QT Interval Prolongation of Amiselimod in Healthy Subjects: A Phase 1 Randomized Controlled Trial.
Hanauer Stephen, O'Reilly Terry, Lester Robert, Slatkin Neal, Lee Jimin, Franklin Howard

Am J Gastroenterol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older.
Stacy B Menees, Howard Franklin, William D Chey

Clin Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying factors associated with clinical success in patients treated with NASHA(®)/Dx injection for fecal incontinence.
Howard Franklin, Andrew C Barrett, Ray Wolf

Clin Exp Gastroenterol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of the ≥50% Response Threshold in Treatment With NASHA/Dx Injection Therapy for Fecal Incontinence.
Jaime E Sanchez, Darren M Brenner, Howard Franklin, Jing Yu, Andrew C Barrett

Clin Transl Gastroenterol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis